Product Information

Straumann® SLActive®

Performance beyond imagination.

2

2 Straumann® SLActive®

FASTER OSSEOINTEGRATION*

To enhance confidence in all treatments

ImmEdIATE lOAdING

High predictability in immediate

loading

ENhANcEd bONE FORmATION8

Significantly higher formation of new bone

aggregate

10 YEARS OF clINIcAl SUccESS ANd PROVEN PREdIcTAbIlITY

*Compared to SLA

3

3 Straumann® SLActive®

For over six decades, Straumann® has made significant contributions to the dental industry, helping to progress the education and technology of dental implants. Through innovation, we’ve made faster treatment and shorter healing time a reality1. SLActive® is designed to provide higher treatment predictability even in challenging protocols to help reduce the overall treatment complexity.

As dental implants are now becoming a mainstream treatment option, clinicians face ever-increasing patient expectations. Patients expect successful treatment results irrespective of their bone quality, age, lifestyle, or medical history.

Achieving predictable treatment outcomes has been the main focus of the SLActive clini-cal development strategy. Together with leading clinicians worldwide, Straumann has studied the clinical performance of SLActive implants under challenging treatment protocols to dem-onstrate the healing capacity of the SLActive surface. As new insights emerge and new data becomes available, discover how you can benefit from the truly phenomenal performance of SLActive to maximize your patients’ healing capabilities.

Setting the standard for success. Performance beyond imagination.

98.2 %survival rate

ImPlANT SURVIVAl RATE IN ImmEdIATE lOAdING

AFTER 10 YEARS2*

Randomized controlled multicenter study

*Based on preliminary data.

4

Immediate loading with long-lasting results.

New long-term data from a randomized, controlled, multicenter study demonstrate the impressive perfor-mance of SLActive® with immediate loading. In fact, the SLActive implants delivered a 10-year survival rate of 98.2 % in this challenging protocol.2*

Increasing patient expectations continue to drive demand for faster, and more efficient treatment protocols. Immediate loading allows the clinician to place a prosthetic restoration on the same day as the implant.

This approach allows a patient to benefit from the restoration immediately. However, this demanding protocol carries a higher risk of failure due to pre-mature loading of a healing implant.

*Based on preliminary data.

Straumann® SLActive®

5

STUdY cONclUSION ѹ SLActive® implants provide a long-term highly

predictable treatment option

Study design

64 Patients

10 yearsStudy follow-up

Indication Maxilla or mandible of partially edentulous patients,

temporary restoration (single crown or 2 – 4 unit fixed partial denture)was replaced by permanent restoration 20 to 23 weeks post surgery

Randomized controlled multicenter study

Weiden, Germany

Coimbra, Portugal

Witten/Herdecke, Germany

Early loading50 implants

(restored after 28 – 34 days)

Immediate loading39 implants

(restored the same day)

Randomized controlled multicenter study

ImPlANT SURVIVAl RATE IN ImmE-dIATE lOAdING AFTER 10 YEARS2*

98.2 %survival rate

*Based on preliminary data.

Straumann® SLActive®

6

Discover the healing power of the high-performance surface.

Straumann® SLActive®

7

Faster healing and increased implant stability is the ultimate goal of an implant surface during osseointegration. This increases the predictability during the early healing phase and leads to a structural and functional connection between vital bone and the implant. The SLActive® surface is designed to provide faster osseointegration, reducing the healing period from 6 – 8 weeks to 3 – 41 weeks in all indications.*

SlAcTIVE® – FASTER bONE FORmATION3

* From single tooth to edentulous

%

%

%

%

%

%

%

%

Healing period in weeks3

% o

f new

bon

e on

Impl

ant s

ucce

ss ra

te* (

%)

the

impl

ant s

urfa

ce

SLA®SLActive®

More than surface technology. An increased level of confidence.

Straumann® SLActive®

8

Reduce healing time from 6 – 8 weeks to 3 – 4 weeks

There is a high risk of early implant loss during the critical early heal-ing phase between 2 – 4 weeks after implant placement.4 SLActive® is designed to deliver better osseointegration properties by achiev-ing secondary stability sooner than hydrophobic surfaces, thereby increasing predictability during the early healing time and reducing the stability dip.5

Stab

ility

SLActive® SLA®

Secondarystability

(new bone)

Primarystability(old bone)

Total stability

80

90

100

Data on file

Weeks

Straumann® SLActive®

9

hIGh STAbIlITY IN EARlY ImPlANT PlAcEmENT POST-ExTRAcTIONThe timing of implant placement post-extraction in the esthetic zone is considered to be an important success factor. Ridge changes after tooth extraction may occur because of bone resorption and may often result in a crater-like bone defect on the facial aspect of the extraction site. SLActive® demonstrates long-term stability of peri-implant hard and soft tissues after 6 years with highly esthetic outcomes in early implant placement.6,7

Hydrophilic properties and chemical activity

Surface based on the scientifically proven SLA®

topography

mm

- mm

- mm

- mm

- mm

- mm

mos. mos. mos. mos. mos. mos.

Crestal bone change displayed by the mean DIB (Distance from implant shoulder to �rst BIC)

Straumann® SLActive®

10

Enhanced bone formation. Even at compromised sites.Bone defects can compromise the predictability of osseointegra-tion. In a recent preclinical study8, SLActive® showed significantly higher formation of new bone aggregate within eight weeks com-pared to the standard Straumann® SLA® hydrophobic surface.

Buccal bone to implant contact was significantly higher in SLActive® groups as compared to standard SLA®, highlighting the benefit of SLActive® to support faster bone integration, in coronal circumferential defects

botiss cerabone®*

SlA®

SlA®

SlActive®

SlActive®

Allograft

Histological views of bone aggregate (new bone and grafting material) 8 weeks post-grafting.

bONE AGGREGATE FORmATION AT 8 WEEKS.

*botiss cerabone is not available in all countries.

Straumann® SLActive®

11

• REDUCE TREATMENT TIME• REDUCE HEALING TIME• REDUCE COMPLEXITY

Please contact your local sales representative to get more information about the advantage of the SLActive surface now or visit www.straumann.us or www.straumann.ca.

Straumann® SLActive®

REFERENCES

1 Straumann SLActive implants compared to Straumann SLA implants. 2 Nicolau P, Guerra F, Reis R, Krafft T, Benz K , Jackowski J 10-year results from a randomized controlled multicenter study with immediately and early loaded SLActive implants in posterior jaws. Accepted for oral presentation at 25th Annual Scientific Meeting of the European Association of Osseointegration – 29 Sep – 1 Oct 2016, Paris. 3 Lang NP, Salvi GE, Huynh-Ba G, Ivanovski S, Donos N, Bosshardt DD. Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans. Clin Oral Implants Res. 2011 Apr;22(4):349-56. doi: 10.1111/j.1600-0501.2011.02172.x. 4 Raghavendra S, Wood MC, Taylor TD. Early wound healing around endosseous implants: a review of the literature. Int J Oral Maxillofac Implants. 2005 May-Jun;20(3):425-31. 5 Oates TW, Valderrama P, Bischof M, Nedir R, Jones A, Simpson J, Toutenburg H, Cochran DL. Enhanced implant stability with a chemically modified SLA surface: a randomized pilot study. Int J Oral Maxillofac Implants. 2007 Sep-Oct;22(5):755-60. 6 Buser D, Wittneben J, Bornstein MM, Grütter L, Chappuis V, Belser UC. Stability of Contour Augmentation and Esthetic Outcomes of Implant-Supported Single Crowns in the Esthetic Zone: 3-Year Result of a Prospective Study With Early Implant Placement Post Extraction. J Periodontol. 2011 March; 82(3): 342-9. 7 Buser D, Chappuis V, Kuchler U, Bornstein MM, Wittneben JG, Buser R, Cavusoglu Y, Belser UC. Long-term Stability of Early Implant Placement with Contour Augmentation. J Dent Res. 2013 Dec;92(12 Suppl):176S-82S. 8 Straumann (2016). SLActive supports enhanced bone formation in a minipig surgical GBR model with coronal circumferential defects. Unpublished data.

International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01

Straumann North American Headquarters Straumann USA, LLC 60 Minuteman Road Andover, MA 01810 Phone 800/448 8168 (US) 800/363 4024 (CA) Fax 978/747 2490 www.straumann.us www.straumann.ca

NAM

LIT

103

0

10/

16

© Straumann USA, LLC 2016. All rights reserved. Straumann® and/or other trademarks and logos from Straumann® that are mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates. All rights reserved.